CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 78994 | LVS EN ISO 10993-17:2023/A1:2025 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/Amd 1:2025) | Standarts spēkā |
| 77182 | EN ISO 14155:2026 | Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2026) | Standarts spēkā |
| 75885 | LVS EN ISO 10993-7:2026 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2026) | Standarts spēkā |
| 77182 | LVS EN ISO 14155:2026 | Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2026) | Standarts spēkā |
| 60724 | EN ISO 10993-16:2017 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO/DIS 10993-16:2016) | Standarts spēkā |
| 74131 | EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
| 77933 | prEN ISO 10993-11 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2026) | Aptauja slēgta |
| 78991 | prEN ISO 10993-16 | Biological evaluation of medical devices - Part 16: Toxicokinetic evaluation for degradation products and leachables (ISO/DIS 10993-16:2025) | Aptauja slēgta |
| 80887 | prEN ISO 10993-4 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO/DIS 10993-4:2026) | Aptauja |
| 9482 | EN ISO 10993-9:1999 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:1999) | Atcelts |
Displaying 51-60 of 200 results.